Shorting MannKind May Be Far More Dangerous Than Some Might Suggest

Shorting MannKind May Be Far More Dangerous Than Some Might Suggest


In an article published yesterday by Seeking Alpha, a fellow contributor made a case for shorting MannKind shares. To his credit, Mr. Amit Ghate's argument was mostly fact-based, built around historical events and drawing heavily on warnings outlined in the small biotechnology concern's latest filing with the Securities & Exchange Commission.



from Biotech News